|

Effect of Face Masks on Pulmonary Function in Patients With COPD

RECRUITINGN/ASponsored by Medical University of Vienna
Actively Recruiting
PhaseN/A
SponsorMedical University of Vienna
Started2022-11-01
Est. completion2025-12
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05742880

Summary

Given the heightened vulnerability of COPD patients to severe illness upon SARS-CoV-2 infection, precautions like mask-wearing are deemed crucial. Yet, mask-wearing can exacerbate breathlessness and discomfort in this demographic. This study aims to assess the effects of wearing a face mask during 6-Minute-Walking-Tests (6-MWT) among COPD patients.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* COPD Diagnosis
* Vaccinated against SARS-CoV 2

Exclusion Criteria:

* Known cardial insufficency
* Long term oxgenation therapy
* immobility
* BMI \>35
* Pregnancy

Conditions2

COPDWalking, Difficulty

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.